A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy.

Galsky, Matthew D; Hahn, Noah M; Rosenberg, Jonathan; Sonpavde, Guru; Hutson, Thomas; Oh, William K; Dreicer, Robert; Vogelzang, Nicholas; Sternberg, Cora; Bajorin, Dean F; Bellmunt, Joaquim

Galsky, Matthew D; Hahn, Noah M; Rosenberg, Jonathan; Sonpavde, Guru; Hutson, Thomas; Oh, William K; Dreicer, Robert; Vogelzang, Nicholas; Sternberg, Cora; Bajorin, Dean F; Bellmunt, Joaquim.

Affiliation

Galsky MD; Tisch Cancer Institute, Mount Sinai School of Medicine, New York NY, USA. matthew.galsky@mssm.edu

Lancet Oncol ; 12(3): 211-4, 2011 Mar.

Article in En | MEDLINE | ID: mdl-21376284

Subject(s)

Urologic Neoplasms/drug therapy; Aged; Antineoplastic Agents/therapeutic use; Cisplatin/therapeutic use; Consensus; Humans; Middle Aged; Urologic Neoplasms/pathology; Urologic Neoplasms/secondary; Urothelium/pathology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urologic Neoplasms Type of study: Guideline Limits: Aged / Humans / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2011 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google